160 related articles for article (PubMed ID: 33498434)
21. Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
Koenig A; Krug S; Mueller D; Barth PJ; Koenig U; Scharf M; Ellenrieder V; Michl P; Moll R; Homayunfar K; Kann PH; Stroebel P; Gress TM; Rinke A
PLoS One; 2017; 12(12):e0188876. PubMed ID: 29232390
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
[No Abstract] [Full Text] [Related]
23. Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based Study.
White BE; Russell B; Remmers S; Rous B; Chandrakumaran K; Wong KF; Van Hemelrijck M; Srirajaskanthan R; Ramage JK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980749
[TBL] [Abstract][Full Text] [Related]
24. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
Chen W; Lu S; Wang G; Chen F; Bai C
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
[TBL] [Abstract][Full Text] [Related]
25. Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining.
Nanayakkara J; Tyryshkin K; Yang X; Wong JJM; Vanderbeck K; Ginter PS; Scognamiglio T; Chen YT; Panarelli N; Cheung NK; Dijk F; Ben-Dov IZ; Kim MK; Singh S; Morozov P; Max KEA; Tuschl T; Renwick N
NAR Cancer; 2020 Sep; 2(3):zcaa009. PubMed ID: 32743554
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Score for Screening Suicide of Patients With Neuroendocrine Neoplasms.
Lu L; Shang Y; Zechner D; Mullins CS; Linnebacher M; Zhang X; Gong P
Front Psychiatry; 2021; 12():638152. PubMed ID: 34177643
[No Abstract] [Full Text] [Related]
27. Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: insights into the metabolic effects of growth hormone.
Abd Rahman S; Schirra HJ; Lichanska AM; Huynh T; Leong GM
Growth Horm IGF Res; 2013; 23(1-2):29-36. PubMed ID: 23380306
[TBL] [Abstract][Full Text] [Related]
28. Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays.
Ramachandran R; Bech P; Murphy KG; Dhillo WS; Meeran KM; Chapman RS; Caplin M; Ghatei MA; Bloom SR; Martin NM
Clin Endocrinol (Oxf); 2012 Jun; 76(6):831-6. PubMed ID: 22175276
[TBL] [Abstract][Full Text] [Related]
29. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
30. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
[TBL] [Abstract][Full Text] [Related]
31. [Discrimination of patients with Xiao-Chaihu Tang syndrome using 1H NMR metabonomics and partial least square analysis].
Xing J; Yuan SC; Sun HM; Fan ML; Li ZY; Qin XM
Yao Xue Xue Bao; 2015 Aug; 50(8):1032-7. PubMed ID: 26669005
[TBL] [Abstract][Full Text] [Related]
32. [Metabonomics Study on Urine 1H-NMR in Chronic Superficial Gastritis Patients with Pi-qi Deficiency Syndrome/Pi-Wei Dampness-heat Syndrome].
Shi XG; Zou ZJ; Wu MY; Zeng YG; Lian ZC; Huang MT; Gong MJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Dec; 35(12):1427-32. PubMed ID: 26882602
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
35. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
[TBL] [Abstract][Full Text] [Related]
36. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
[TBL] [Abstract][Full Text] [Related]
37. Metabonomic signature analysis in plasma samples of glioma patients based on (1)H-nuclear magnetic resonance spectroscopy.
Kelimu A; Xie R; Zhang K; Zhuang Z; Mamtimin B; Sheyhidin I
Neurol India; 2016; 64(2):246-51. PubMed ID: 26954801
[TBL] [Abstract][Full Text] [Related]
38. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of Neuroendocrine Tumors.
Fraenkel M; Faggiano A; Valk GD
Front Horm Res; 2015; 44():1-23. PubMed ID: 26303701
[TBL] [Abstract][Full Text] [Related]
40. Analysis of metabolomic patterns in thoroughbreds before and after exercise.
Jang HJ; Kim DM; Kim KB; Park JW; Choi JY; Oh JH; Song KD; Kim S; Cho BW
Asian-Australas J Anim Sci; 2017 Nov; 30(11):1633-1642. PubMed ID: 28728374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
